Confirmatory study of BK-4SP in healthy infants.

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221090

Enrollment

326

Registered

2010-05-25

Start date

2010-05-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis of pertussis, diphtheria, tetanus, and poliomyelitis infection.

Interventions

investigational material(s) Generic name etc : BK-4SP INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : subcutaneous

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age: greater than 3months old ,less than 74 months old

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Immunogenicity	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026